Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.08 - $809.55 $5,157 - $52.2 Million
64,470 New
64,470 $5,000
Q2 2022

Aug 15, 2022

SELL
$0.27 - $0.71 $2,870 - $7,548
-10,631 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.38 - $1.07 $14,268 - $40,177
-37,549 Reduced 77.93%
10,631 $8,000
Q4 2021

Feb 14, 2022

BUY
$1.03 - $2.48 $49,625 - $119,486
48,180 New
48,180 $50,000

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $127M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.